company? Let’s change
that.
Don't see your company?
Create a company profileIllumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
OUR MISSION: Empower Discovery. Enable Innovation. Improve Life. For over 25 years, Mirus Bio has pioneered the development of transfection reagents and proprietary technologies for nucleic acid delivery applications. Our work is both technical and cutting-edge, and we promote a culture of creativity, responsibility, and respect. Our team members are engaged and motivated by the desire to support our customers and partners to achieve strong results. Mirus, together with Gamma Biosciences, is establishing the future of science and medicine by developing products that enable product developers within the cell and gene therapy space. As we approach a new era of addressing and conquering life-altering diseases, we will continue to expand our expertise and leadership in transfection to be integral in the future of advanced therapies. Mirus Bio is a Gamma Biosciences Company.
At Accuray, we make a direct and powerful impact on the lives of cancer patients every day — helping them live longer, better lives. But our commitment to innovation offers a truly unique opportunity: the chance to change the fight against cancer — helping to develop, introduce and support new treatment delivery systems and software that will give new hope and new health to cancer patients and cancer survivors around the world. Accuray develops, manufactures and sells radiotherapy systems for alternative cancer treatments. Our radiation therapy for cancer makes treatment shorter, safer, personalized and more effective, ultimately enabling patients to live longer, better lives.
Cellscript is a pharmaceutical company
BioSentinel develops innovative tools and reagents for the study of botulinum neurotoxin (BoNT).
Alpha Universe offers products for cell biology and molecular biology.
EyeKor is a network of established reading centers and clinical trial experts.
Platypus Technologies develops analytical and life sciences products based upon the application of nanotechnology and materials science.
Fujifilm Cellular Dynamics, Inc. develops and manufactures biologically relevant human cells derived from induced pluripotent stem (iPS) cells. Our iCell® and donor-specific MyCell® Products are highly pure, highly reproducible, and available in industrial quantity to enable drug discovery, toxicity testing, stem cell banking, and cell therapy development.
Capio Biosciences focuses on delivering high-value oncology diagnostics that can help inform patient care decisions and improve outcomes.
Intuitive Biosciences provides tuberculosis and specific pathogen-free tests for non-human primate (NHP) research operations.
Atterx develops therapeutics to fight the growing epidemic of antibiotic resistant bacteria.
Invenra is focused on developing the next generation of best-in-class biologics, with an emphasis on multispecific antibodies and their derivatives. Invenra's proprietary technologies combine our highly developable B-Body™ bispecific platform with high throughput functional screening, enabling the optimization of unprecedented numbers of bispecific antibodies in phenotypic assays. Invenra has a pipeline of immuno-oncology bispecific antibodies that are currently in preclinical studies.
Nimble Therapeutics is bringing the power of massively parallel chemical synthesis to drug discovery.
FluGen is a biopharmaceutical company specializing on the prevention and treatment of seasonal and pandemic influenza worldwide.
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
Genome International Corporation (GIC) is a research-driven firm.
Cellara is an early-stage Madison, Wisconsin-based biotechnology company developing workflow solutions to address critical issues.
Proteovista is a microarray technology and applications for basic research and drug discovery company
Centrose is a biotechnology company engaged in the development and commercialization of therapeutics targeting disease related cells.
Work Your Passion. Live Your Purpose.